FDA Approves Alexza's (ALXA) Adusave
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- US stock index futures subdued as oil, Treasury yields rise on Iran tensions
- Oil prices steady as traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Dollar hits two-week high, Middle East conflict and rate paths in focus
- Is the ECB’s hawkish shift just beginning to bite? UBS weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Alexza Pharma (ALXA) Resumes, Shares Move Lower
December 21, 2012 4:15 PM ESTAlexza Pharma (NASDAQ: ALXA) shares resume trading, shares are down 6 percent late Friday.... More
Alexza Pharma (ALXA) to resume trading at 4:15pm ET
December 21, 2012 3:31 PM ESTAlexza Pharma (NASDAQ: ALXA) to resume trading at 4:15pm EST.... More
Alexza Pharma (ALXA) trading halted with news pending
December 21, 2012 2:40 PM ESTAlexza Pharma (NASDAQ: ALXA) trading halted with news pending.... More
Sentiment Behind FDA Approval of Alexza's (ALXA) Adusave Improves; Shares Higher Today
December 20, 2012 12:31 PM ESTAlexza Pharmaceuticals (Nasdaq: ALXA) is higher on the session amid positive sentiment behind its Adasuve receiving FDA approval tomorrow.
Last week, Alexza reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a... More
